Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.

Taha, Mondal, Sandhyavenu, Atti, Alhajji, Thangjui, Shaik, Thyagaturu, Caccamo, Fonarow, & Balla (2026). Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.. The American journal of cardiology.

Taha, Mondal, Sandhyavenu, Atti, Alhajji, Thangjui, et al. Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.. The American journal of cardiology. 2026; PMID: 42144123

Taha, Mondal, Sandhyavenu, et al. Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.[J]. The American journal of cardiology. 2026.

@article{taha2026,
  author = {Taha and Mondal and Sandhyavenu and Atti and Alhajji and Thangjui and Shaik and Thyagaturu and Caccamo and Fonarow and Balla},
  title = {Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.},
  journal = {The American journal of cardiology},
  year = {2026},
  note = {PMID: 42144123},
}

TY  - JOUR
AU  - Taha
AU  - Mondal
AU  - Sandhyavenu
AU  - Atti
AU  - Alhajji
AU  - Thangjui
AU  - Shaik
AU  - Thyagaturu
AU  - Caccamo
AU  - Fonarow
AU  - Balla
TI  - Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study.
T2  - The American journal of cardiology
PY  - 2026
AN  - PMID:42144123
ER  -